This signposted external event is not commissioned, organized or facilitated by C&P Training Hub. The availability of these offers are not checked on a daily basis and bookings are done directly with the supplier. You will not be able to see these on your Training Hub Account. Please contact the supplier directly if you have any questions, their contact details should be on your confirmation e-mails.

The “The Cardio-Renal Connection:  Early Identification of CKD via ACR and CVD Management in Diabetes”  Webinar is free to access both live and on-demand for attendees. To watch on-demand without attending the webinar you can join the Associate Programmme.

Learning objectives

By the end of the webinar, delegates should be able to: 

  • Explain the importance of ACR in the early identification and assessment of kidney disease in primary care. 
  • Interpret ACR results alongside eGFR and recognise patients who may require further investigation or intervention. 
  • Identify opportunities for medicines optimisation and risk reduction in patients with albuminuria. 
  • Describe the key factors contributing to cardiovascular risk in people with diabetes. 
  • Recognise opportunities to optimise lipid, blood pressure and diabetes management to reduce cardiovascular risk. 
  • Discuss the role of SGLT2 inhibitors and GLP-1 receptor agonists in reducing cardiovascular and renal risk where appropriate. 
  • Apply a holistic, risk-based approach to medicines optimisation in people with diabetes. 

ACR & Early Identification of Kidney Disease in Primary Care

  • Why ACR matters? 
  • Who should we be testing? 
  • Interpreting ACR results 
  • What can primary care pharmacists do? 

Cardiovascular Risk in Diabetes

  • Why cardiovascular risk matters in diabetes  
  • Assessing cardiovascular risk  
  • Lipid management & primary prevention 
  • Beyond glucose lowering